首页> 外文会议>Symposium on Risk Assessment of Phytochemicals in Food: Novel Approaches >Evaluation of the Cytotoxic Effects of Herbal Homeopathic Extracts in Primary Human Hepatocytes In Vitro
【24h】

Evaluation of the Cytotoxic Effects of Herbal Homeopathic Extracts in Primary Human Hepatocytes In Vitro

机译:在体外原发性人肝细胞中草药同种疗法提取物的细胞毒性作用评价

获取原文

摘要

In Europe, Petasites hybridus L. (butterbur) and Chelidonium majus L. (greater celandine) are being used for centuries in traditional and folk medicine. Even today, preparations from these plants represent valuable products in homeo-pathic and anthroposophic medicine, e.g. for the treatment of liver dysfunction (Chelidonium) and asthma or migraine (Petasites). Although both plants have been associated with a potential to cause hepatotoxic effects in vitro and in vivo, experimental data are insufficient to draw final conclusions and to determine toxicological threshold levels, especially for Petasites. In order to elucidate the hepatotoxic potential of mother tinctures from C. majus (HAB, Vs. 34b) and P. hybridus (HAB Vs. 33c), their toxicity was studied in primary human hepato-cytes under GLP conditions. Due to the fact that primary human hepatocytes include almost the complete set of metabolic enzymes of the human organism preserving also the inducibility of the enzymes, they are recommended by vari-ous test guidelines [1]. In this sense they are suitable to evaluate hepatotoxic and cytotoxic effects in vitro and to investigate fundamental aspects of drug metabolism-linked toxicity.
机译:在欧洲,佩拉西斯·含氟盐葡萄球菌L.(毛皮)和Chelidonium Majus L.(较大的Celandine)在传统和民间医学中使用了几个世纪。即使在今天,这些植物的制剂也代表了家庭公众和人类学医学中的有价值的产品。用于治疗肝功能障碍(Chelidonium)和哮喘或偏头痛(叶柄)。尽管两种植物都与在体外和体内引起肝毒性效应的可能性相关,但实验数据不足以吸取最终结论并确定毒理学阈值水平,特别是对于佩塔斯。为了阐明来自C.Majus(HAB,Vs.34b)和P. hybridus(Hab与33c)的母酊的肝毒性潜力,在GLP条件下,在原发性人肝细胞中研究了它们的毒性。由于这样的事实,原代人肝包括几乎全套人的机体还保留了酶的诱导能力的代谢酶,它们是由VARI-OU中测试规范[1]中推荐。从这个意义上,它们适合于在体外评估肝毒性和细胞毒性作用,并调查药物代谢联系毒性的基本方面。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号